Xylopine
AlkaPlorer ID: AK006135
Synonym: 'Xylopine', '(-)-Xylopine'
IUPAC Name: (12R)-16-methoxy-3,5-dioxa-11-azapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14(19),15,17-hexaene
Structure
SMILES: COC1=CC=C2C(=C1)C[C@H]1NCCC3=CC4=C(OCO4)C2=C31
InChI: InChI=1S/C18H17NO3/c1-20-12-2-3-13-11(6-12)7-14-16-10(4-5-19-14)8-15-18(17(13)16)22-9-21-15/h2-3,6,8,14,19H,4-5,7,9H2,1H3/t14-/m1/s1
InChIKey: RFWCCZDSXIZJMF-CQSZACIVSA-N
Reference
PubChem CID: 160503
CAS: 517-71-5
LOTUS: LTS0176542
SuperNatural Ⅲ: SN0324216-02
NPASS: NPC86144
data_source: manually
Source
Properties Information
Molecule Weight: 295.338
TPSA?: 39.72
MolLogP?: 2.833800000000001
Number of H-Donors: 1
Number of H-Acceptors: 4
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Homo sapiens | A-431 | ED50 | 4.6 | ug ml-1 | 10.1021/np50099a005 |
| Homo sapiens | HT-1080 | ED50 | 2.2 | ug ml-1 | 10.1021/np50099a005 |
| Homo sapiens | KB | ED50 | 2.0 | ug ml-1 | 10.1021/np50099a005 |
| Homo sapiens | LNCaP | ED50 | 2.4 | ug ml-1 | 10.1021/np50099a005 |
| Homo sapiens | SK-MEL-2 | ED50 | 12.6 | ug ml-1 | 10.1021/np50099a005 |
| Homo sapiens | ZR-75-1 | ED50 | 2.4 | ug ml-1 | 10.1021/np50099a005 |
| Mus musculus | P388 | ED50 | 2.2 | ug ml-1 | 10.1021/np50099a005 |
| Plasmodium falciparum | Plasmodium falciparum | ED50 | 440.0 | ng/ml | 10.1021/np50099a005 |
| Plasmodium falciparum | Plasmodium falciparum | ED50 | 2270.0 | ng/ml | 10.1021/np50099a005 |
| None | NON-PROTEIN TARGET | ED50 | 0.9 | ug ml-1 | 10.1021/np50099a005 |
| None | NON-PROTEIN TARGET | ED50 | 1.9 | ug ml-1 | 10.1021/np50099a005 |
| None | NON-PROTEIN TARGET | ED50 | 2.3 | ug ml-1 | 10.1021/np50099a005 |
| None | NON-PROTEIN TARGET | ED50 | 3.4 | ug ml-1 | 10.1021/np50099a005 |
| None | NON-PROTEIN TARGET | ED50 | 4.1 | ug ml-1 | 10.1021/np50099a005 |
| None | Unchecked | Ratio ED50 | 9.0 | None | 10.1021/np50099a005 |
| None | Unchecked | Ratio ED50 | 45.0 | None | 10.1021/np50099a005 |
